{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:57:05Z","timestamp":1771009025753,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"9155","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1016\/s0140-6736(98)06475-7","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T00:46:25Z","timestamp":1027644385000},"page":"797-801","source":"Crossref","is-referenced-by-count":332,"title":["Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial"],"prefix":"10.1016","volume":"353","author":[{"given":"WY","family":"Lau","sequence":"first","affiliation":[]},{"given":"TWT","family":"Leung","sequence":"additional","affiliation":[]},{"given":"SKW","family":"Ho","sequence":"additional","affiliation":[]},{"given":"M","family":"Chan","sequence":"additional","affiliation":[]},{"given":"D","family":"Machin","sequence":"additional","affiliation":[]},{"given":"J","family":"Lau","sequence":"additional","affiliation":[]},{"given":"ATC","family":"Chan","sequence":"additional","affiliation":[]},{"given":"W","family":"Yeo","sequence":"additional","affiliation":[]},{"given":"TSK","family":"Mok","sequence":"additional","affiliation":[]},{"given":"SCH","family":"Yu","sequence":"additional","affiliation":[]},{"given":"NWY","family":"Leung","sequence":"additional","affiliation":[]},{"given":"PJ","family":"Johnson","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(98)06475-7_bib1","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/1097-0142(19951215)76:12<2443::AID-CNCR2820761207>3.0.CO;2-F","article-title":"Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients","volume":"76","author":"Ng","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(98)06475-7_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01656375","article-title":"The surgical management of primary carcinoma of the liver","volume":"6","author":"Lee","year":"1982","journal-title":"World J Surg"},{"key":"10.1016\/S0140-6736(98)06475-7_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000658-199108000-00004","article-title":"Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis","volume":"241","author":"Belghiti","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/S0140-6736(98)06475-7_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000658-199001000-00005","article-title":"Postoperative recurrence of hepatocellular carcinoma","volume":"211","author":"Nagao","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/S0140-6736(98)06475-7_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/1097-0142(19900301)65:5<1104::AID-CNCR2820650511>3.0.CO;2-G","article-title":"Prognostic factors after hepatectomy for hepatocellular carcinomas, a univariate and multivariate analysis","volume":"65","author":"Yamanaka","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(98)06475-7_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO;2-I","article-title":"Risk factors for tumour recurrence and prognosis after curative resection of hepatocellular carcinoma","volume":"71","author":"Ikeda","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(98)06475-7_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ajcp\/90.5.536","article-title":"Selective and persistent deposition and gradual drainage of iodized oil, lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery","volume":"90","author":"Okayasu","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S0140-6736(98)06475-7_bib8","first-page":"1038","article-title":"Dosimetry of iodine-131 ethiodol in the treatment of hepatoma","volume":"29","author":"Madsen","year":"1988","journal-title":"J Nucl Med"},{"issue":"suppl","key":"10.1016\/S0140-6736(98)06475-7_bib9","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1007\/BF00686684","article-title":"Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labelled lipiodol","volume":"33","author":"Yoo","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/S0140-6736(98)06475-7_bib10","first-page":"1313","article-title":"Selective internal radiation therapy with intraarterial 131iodine-lipiodol in inoperable hepatocellular carcinoma","volume":"35","author":"Leung","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/S0140-6736(98)06475-7_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003072-199603000-00008","article-title":"Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma","volume":"21","author":"Maini","year":"1996","journal-title":"Clin Nucl Med"},{"key":"10.1016\/S0140-6736(98)06475-7_bib12","first-page":"1156","article-title":"Prospective randomised trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma","volume":"26","author":"Raoul","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/S0140-6736(98)06475-7_bib13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(98)06475-7_bib15","first-page":"988","article-title":"Reduction of local recurrence after adjuvant intra-arterial lipiodol-ioidine-131 for hepatocellular carcinoma\u2014a planned interim analysis of a prospective randomized study","volume":"16","author":"Leung","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/S0140-6736(98)06475-7_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/bjs.1800830313","article-title":"Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma","volume":"83","author":"Yamamoto","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/S0140-6736(98)06475-7_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9610(99)80184-6","article-title":"Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma","volume":"169","author":"Takenaka","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/S0140-6736(98)06475-7_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/hep.1840200205","article-title":"Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma","volume":"20","author":"Izumi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/S0140-6736(98)06475-7_bib19","first-page":"183","article-title":"Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial","volume":"133","author":"Lai","year":"1993","journal-title":"Arch Surg"},{"key":"10.1016\/S0140-6736(98)06475-7_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199606133342402","article-title":"Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma","volume":"334","author":"Muto","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(98)06475-7_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1097-0142(19920701)70:1<40::AID-CNCR2820700107>3.0.CO;2-P","article-title":"Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?","volume":"70","author":"Leung","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(98)06475-7_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2307\/2531962","article-title":"Interim analyses in randomised clinical trials: ramifications and guidelines for practitioners","volume":"43","author":"Geller","year":"1987","journal-title":"Biometrics"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673698064757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673698064757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T13:58:04Z","timestamp":1555423084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673698064757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":21,"journal-issue":{"issue":"9155","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S0140673698064757"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(98)06475-7","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}